SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-038450
Filing Date
2024-03-25
Accepted
2024-03-25 16:11:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm249641d1_s3.htm S-3 237232
2 EXHIBIT 5.1 tm249641d1_ex5-1.htm EX-5.1 10744
3 EXHIBIT 23.1 tm249641d1_ex23-1.htm EX-23.1 2766
4 EXHIBIT 107 tm249641d1_ex-filingfees.htm EX-FILING FEES 13226
5 GRAPHIC tm249641d1_s3img001.jpg GRAPHIC 18322
6 GRAPHIC tm249641d1_ex5-1img001.jpg GRAPHIC 12975
  Complete submission text file 0001104659-24-038450.txt   308563
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-278209 | Film No.: 24779330
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)